Cost increases were particularly pronounced among patients with severe systemic lupus erythematosus (SLE), the study found. A new study based on real-world spending shows how a diagnosis of systemic ...
Systemic lupus erythematosus (SLE), the prototypic systemic autoimmune disease, has protean clinical manifestations, including potentially fatal involvement of the kidneys (glomerulonephritis) and ...
Systemic lupus erythematosus (SLE) is the most common type of lupus, a chronic autoimmune disease. Symptoms include fatigue, joint pain, and rashes across your nose and cheeks. While there’s no cure, ...
Systemic lupus erythematosus (SLE) is an autoimmune disease, in which the immune system that normally protects the body from invading microbes turns against the body's own cells. Researchers studied ...
CD19 chimeric antigen receptor (CAR) T-cell therapy showed potential in treating patients with refractory systemic lupus erythematosus (SLE), with B-cell depletion and disease activity reduction ...
Among patients with new-onset systemic lupus erythematosus (SLE), 23% experienced one or more thromboembolic events (TEs). The incidence of TEs in antiphospholipid antibody-positive patients diagnosed ...
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent ...
Systemic lupus erythematosus (SLE) is the most common form of lupus — it’s the type that 7 in 10 people with lupus have. It's what most people mean when they say "lupus." Experts don’t know what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback